Tag: GLP-1

US

Ozempic maker Novo Nordisk wants the FDA to stop pharmacies from making off-brand versions of popular weight loss meds

October 23, 2024
CyberSec Bulletin

In This Story Ozempic maker Novo Nordisk (NVO-0.61%) is asking the U.S. Food and Drug Administration…